Korsana Biosciences KRSA
NASDAQ KRSA
$30.49 -0.71 (-2.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

Korsana Biosciences (KRSA) Return on Capital Employed [ROCE] (2019 - 2025)

Updated

Korsana Biosciences (KRSA) posted Return on Capital Employed [ROCE] of -40.30% for Q3 2025, up 27.17 percentage points from -67.47% a year earlier and up 2.33 percentage points from the prior quarter.

Analysis

Korsana Biosciences (KRSA) Return on Capital Employed [ROCE] (2019 - 2025) Analysis & Trends

For FY2024, Korsana Biosciences' Return on Capital Employed [ROCE] came in at -33.75%, up 61.19 percentage points from FY2023.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +125.15 percentage points (FY2019 to FY2024).
  • In prior years, Korsana Biosciences' Return on Capital Employed [ROCE] was -94.95% in FY2023 (-35.29 pp), -59.66% in FY2022 (+12.71 pp), -72.37% in FY2021 (-11.71 pp) and -60.66% in FY2020 (+98.24 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -354.88% in Q1 2023 to a high of -40.11% in Q1 2025 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last nine quarters, with an average year-over-year change of +104.57 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2024, with a gain of 251.54 percentage points; the weakest was Q1 2023, with a drop of 228.76 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -42.63% (Q2 2025), -40.11% (Q1 2025) and -42.62% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Korsana Biosciences 16.10 Mn 1.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -40.30%
Jun 30, 2025 -42.63%
Mar 31, 2025 -40.11%
Dec 31, 2024 -42.62%
Sep 30, 2024 -67.47%
Jun 30, 2024 -114.62%
Mar 31, 2024 -103.34%
Dec 31, 2023 -106.08%
Sep 30, 2023 -151.34%
Jun 30, 2023 -242.10%
Mar 31, 2023 -354.88%
Dec 31, 2022 -253.89%
Sep 30, 2022 -209.56%
Jun 30, 2022 -167.78%
Mar 31, 2022 -126.12%
Dec 31, 2021 -105.23%
Sep 30, 2021 -99.50%
Jun 30, 2021 -91.25%
Mar 31, 2021 -78.63%
Dec 31, 2020 -76.35%
API Access

Korsana Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KRSA&period=max&api_key=YOUR_API_KEY